Natasha Giordano
2019
In 2019, Natasha Giordano earned a total compensation of $1.6M as President, Chief Executive Officer and Director at Dipexium Pharmaceuticals, a 162% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $265,000 |
|---|---|
| Option Awards | $865,751 |
| Salary | $468,750 |
| Other | $16,000 |
| Total | $1,615,501 |
Giordano received $865.8K in option awards, accounting for 54% of the total pay in 2019.
Giordano also received $265K in non-equity incentive plan, $468.8K in salary and $16K in other compensation.
Rankings
In 2019, Natasha Giordano's compensation ranked 6,959th out of 13,971 executives tracked by ExecPay. In other words, Giordano earned more than 50.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,959 out of 13,971 | 50th |
Division Manufacturing | 2,660 out of 5,695 | 53rd |
Major group Chemicals And Allied Products | 971 out of 2,194 | 56th |
Industry group Drugs | 821 out of 1,880 | 56th |
Industry Pharmaceutical Preparations | 602 out of 1,392 | 57th |
Source: SEC filing on September 25, 2020.
Giordano's colleagues
We found three more compensation records of executives who worked with Natasha Giordano at Dipexium Pharmaceuticals in 2019.